DELVE Trademark

Trademark Overview

On Friday, November 3, 2023, a trademark application was filed for DELVE with the United States Patent and Trademark Office. The USPTO has given the DELVE trademark a serial number of 98254371. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, June 27, 2024. This trademark is owned by Flagship Labs 89, Inc.. The DELVE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; therapeutic pharmaceuticals for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, ...

Medical research and development; research and development in the field of computational biology, bioinformatics, genetics, genomics, biotechnology, pharmaceuticals, and therapeutics; platform as a service (PaaS) featuring computer software platforms for drug discovery; pharmaceutical and biopharmaceutical research and development; drug development services, namely, pharmaceutical drug development services; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for enabling research and development of pharmaceutical data in the field of computational biology, bioinformatics, genetics, genomics, biotechnology and pharmaceuticals; DNA, RNA, and genomic analysis and sequencing services for medical research purposes; none of the foregoing relating to finding people scientific studies to participate in or recruiting participants for scientific studi...
delve

General Information

Serial Number98254371
Word MarkDELVE
Filing DateFriday, November 3, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; therapeutic pharmaceuticals for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases
Goods and ServicesMedical research and development; research and development in the field of computational biology, bioinformatics, genetics, genomics, biotechnology, pharmaceuticals, and therapeutics; platform as a service (PaaS) featuring computer software platforms for drug discovery; pharmaceutical and biopharmaceutical research and development; drug development services, namely, pharmaceutical drug development services; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for enabling research and development of pharmaceutical data in the field of computational biology, bioinformatics, genetics, genomics, biotechnology and pharmaceuticals; DNA, RNA, and genomic analysis and sequencing services for medical research purposes; none of the foregoing relating to finding people scientific studies to participate in or recruiting participants for scientific studies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePROLOGUE MEDICINES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameFlagship Labs 89, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, January 24, 2024NON-FINAL ACTION E-MAILED
Monday, November 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 19, 2024ASSIGNED TO EXAMINER
Wednesday, January 24, 2024NON-FINAL ACTION WRITTEN
Wednesday, January 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 4, 2024NON-FINAL ACTION WRITTEN
Monday, March 4, 2024NON-FINAL ACTION E-MAILED
Monday, March 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2024LETTER OF SUSPENSION E-MAILED
Thursday, June 27, 2024SUSPENSION LETTER WRITTEN
Thursday, June 27, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

delve diseases disorders development pharmaceutical research pharmaceuticals drug genomic services biology